semaglutide and liver disease treats MASH essence trial semaglutide Metabolic dysfunction-associated

Waters bridging interactions with ligand are shown as ball-and-stick model

The compound is currently FDA-approved under two brand names: Mounjaro for the treatment of type 2 diabetes Zepbound for chronic weight management in obese or overweight individuals Clinical trials have highlighted Tirzepatides superior weight-loss effects compared to other GLP-1 drugs

After 4 weeks: If needed, increase your dose to 5 mg once a week

It supports satiety, metabolic health, and lean mass preservation throughout life

There is no medical contraindication to concurrent use, and patients should generally continue Wegovy when prescribed antibiotics for bacterial infections, unless your clinician advises a temporary delay or adjustment due to severe gastrointestinal illness or dehydration